Engflag

Copper Sulphate

Quick links to important sections

Copper Sulphate

There is no image.

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Copper Sulphate

Quick Facts: Copper Sulphate Identity

Property Description
Active Ingredient Copper Sulphate (Cupric Sulfate, CuSO4)
Primary Form Sterile Liquid Solution (for Injection)
Pharmacological Class Essential Trace Element; Mineral/Electrolyte Supplement
Origin Synthetic; Inorganic Salt
Role Source of the essential cupric cation (Cu^2+)

What Type of Medicine is Copper Sulphate?

Copper Sulphate is an inorganic salt synthesized for medical purposes and is classified pharmacologically as an Essential Trace Element and a Mineral/Electrolyte Supplement. This classification reflects that the body requires it in small, necessary amounts to function properly, though it cannot produce the element itself. Unlike targeted drugs, its primary function is to maintain systemic balance. The requirements for this compound in pharmaceutical formulations are governed by official established standards for purity and composition.

Copper is recognized for its role as a cofactor for metalloenzymes necessary for processes like cellular respiration and protecting the body from oxidative damage. This foundational role means the body needs an adequate copper supply to sustain essential functions like energy production and cellular defense. Nutritional products containing this active ingredient include specialized brands that often combine it with other essential micronutrients in sterile, injectable solutions.

What are the Pharmaceutical Forms and General Purpose?

In clinical settings, Copper Sulphate is most commonly supplied as a Sterile Liquid Solution prepared for Intravenous (Parenteral) administration. This route allows for the delivery of the mineral directly into the bloodstream, which is a standard approach for patients requiring Total Parenteral Nutrition (TPN). Its general purpose is to prevent or correct copper deficiency by ensuring a constant and adequate nutrient supply.

Intravenous nutritional products containing Copper Sulphate are manufactured under strict standards to ensure consistency and quality. These standards help ensure that the product provides the necessary cupric cation to support blood cell formation and nervous system health. It is utilized in clinical scenarios involving long-term intravenous feeding, where Copper Sulphate is administered to stabilize a patient's nutritional status.

Regulatory References

  1. Cupric Sulfate Monograph (USP)

What side effects are possible with Copper Sulphate?

Copper Sulphate: Possible Side Effects and Safety Information

Adverse Reaction Profile

Gastrointestinal and Acute Effects: Copper Sulphate is officially classified as Harmful if swallowed (Acute Toxicity Category 4). Ingestion may cause immediate and severe adverse reactions, including nausea, vomiting, diarrhea, abdominal pain, and a metallic taste. Acute poisoning can potentially lead to more serious outcomes, such as tissue corrosion, shock, and damage to the liver and kidneys.

Local and Contact Reactions: Direct contact with this substance is documented to cause significant local effects. It Causes serious eye damage (Category 1 or 2A), which can result in redness, pain, blurred vision, and corneal injury. Contact with the skin can cause irritation (Category 2) and may also lead to a skin allergy (sensitization).

Systemic and Chronic Concerns: Repeated or prolonged exposure, such as inhalation of the dust or fume, has been associated with irritation of the respiratory tract, potentially causing coughing, sore throat, and damage to the nasal septum. Long-term exposure, particularly in cases of systemic absorption, may have effects on the liver and kidneys, potentially resulting in impaired function.

Safety Classifications and Restrictions

Regulatory Classifications: Authoritative sources utilize the Globally Harmonized System (GHS) and similar governmental frameworks for hazard classification, noting its potential to be a mutagen (cause genetic changes) and is officially Suspected of damaging the unborn child (Reproductive Toxicity Category 2) in some regions. Specific occupational exposure limits are defined for copper dusts and fumes.

Population-Specific Considerations: Individuals with Wilson's Disease, a genetic condition affecting copper metabolism, may be at an increased risk of toxicity from copper exposure. Consumption of alcohol may also exacerbate the risk of liver damage.

Safety Restrictions: Strict regulatory notes mandate the use of appropriate Personal Protective Equipment (PPE) to prevent skin, eye, and inhalation exposure. Additionally, Copper Sulphate is classified as Very toxic to aquatic life with long lasting effects, imposing mandatory restrictions on its release into the environment.

The official safety information highlights that the primary risks are centered on its corrosive properties upon direct contact and its potential for systemic organ toxicity following ingestion or chronic exposure, framing its use around stringent risk mitigation measures.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define copper sulphate overdose by its potential for severe, multi-systemic toxicity, necessitating immediate emergency medical care.

Overdose may present acutely with severe gastrointestinal symptoms, including a metallic taste, vomiting, diarrhea, and abdominal pain, alongside neurological signs such as encephalopathy.

Life-Threatening Manifestations

  • Massive acute overexposure carries the risk of multi-organ failure, involving the kidney, liver, blood (including hemolysis), and cardiovascular systems.
  • Regulatory labeling states that severe toxicity may be fatal.

Emergency Actions and Treatment

When acute toxicity is suspected, immediate medical attention is required. The official regulatory action for managing acute overdose is the utilization of chelating agents.

  • The specific chelator D-penicillamine is reported as effective for the treatment of acute toxicity.

Population Considerations

Patients with underlying conditions like cholestasis or cirrhosis are noted to be at increased risk of hepatic accumulation due to impaired biliary excretion. Similarly, administration to patients with Wilson disease is associated with an increased risk of aggravation and copper accumulation. Both high serum levels and chronic over-administration resulting in tissue accumulation pose significant risk for possible organ damage.

Therapeutic Uses of Copper Sulphate

What Copper Sulphate Treats: Main Uses and Benefits

The injectable form of this trace element is applied in addressing acquired copper deficiency (Hypocupremia), a condition presenting with systemic imbalance where the body needs supportive mineral management. The treatment is considered relevant for use in Total Parenteral Nutrition (TPN) protocols, where supportive mineral management is needed to assist with managing subsequent deficiency symptoms.

Copper supplementation is generally used across domains where additional symptomatic support is needed due to nutritional shortfall. Key therapeutic areas include managing deficiency-related hematological syndromes (like specific anemias and neutropenia), supporting the health of the nervous system (addressing neuropathy and difficulties with coordination), and assisting with bone structure. This application is relevant in high-risk patient groups, such as those with severe malabsorption or post-bariatric surgery.

“This therapy provides foundational support, helping the body restore essential micronutrient balance.”

The use of this medication contributes to easing the overall symptom load of fatigue and pallor, and plays a role in supporting the functioning of copper-dependent processes that are vital for physical stability and comfort.

Quick Fact: Relief for Deficiency Symptoms
Primary Use Context Supplementation during long-term Total Parenteral Nutrition (TPN)
Symptom Clusters Addressed Anemia, Neutropenia, Peripheral Neuropathy, Weakness
Patient Benefit Supports maintenance of functional stability and essential blood cell formation

Regulatory References

  1. DailyMed prescribing information from the NIH

Eligibility and Restrictions for Use

Official Eligibility Profile: Who Can and Cannot Use Copper Sulphate

This section outlines the population eligibility and non-eligibility for copper sulfate (typically administered as an injection for trace element supplementation) based strictly on authoritative government regulatory documents.

Populations Who Must Not Use Copper Sulphate

Classification Population/Condition
Contraindicated Patients with known hypersensitivity (allergy) to copper or cupric chloride.
Not Recommended Patients with Wilson disease, an inherited disorder of copper metabolism, due to the high risk of increased copper accumulation and toxicity.

Populations Requiring Special Consideration or Restricted Use

Eligibility is conditional, requiring close monitoring and potential dose adjustment for the following groups:

  • Hepatic Impairment: Patients with cholestasis, biliary dysfunction, or cirrhosis must be closely monitored due to reduced biliary excretion, which increases the risk of hepatic accumulation of copper.
  • Renal Impairment: Patients with impaired kidney function, including premature neonates, are at increased risk of aluminum toxicity from the product.
  • Pregnancy and Lactation: Use is conditional. It is not known if the drug causes fetal harm or is excreted in human milk; it should be given only if clearly indicated by a healthcare professional.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The officially documented interaction profile for injectable Copper Sulphate (Cupric Sulfate) focuses on chemical incompatibility within solution admixtures and essential mineral balance interactions, rather than metabolic drug-drug interactions.

Admixture and Mineral Interactions

Interacting Substance/Condition Official Regulatory Restriction or Outcome
Ascorbic Acid (Vitamin C) & Multivitamins The cupric ion may cause the degradation of Ascorbic Acid when compounded in Total Parenteral Nutrition (TPN) solutions, resulting in a loss of the vitamin’s exposure.
Timing with Multivitamin Additives Multivitamin additives must be administered immediately prior to infusion or the copper must be added to a separate container to prevent chemical degradation.
Zinc (Mineral Supplement) Co-administration of the essential trace element zinc is known to affect homeostasis and may cause a decrease in serum copper levels.
Penicillamine (Chelating Agent) Copper acts as a pharmacodynamic antagonist that is formally documented to decrease the therapeutic effect of this chelating agent.

Clearance Alteration

Hepatic and/or Biliary Tract Dysfunction (such as cholestasis or cirrhosis) is officially noted to cause decreased clearance of copper, which raises the risk of accumulation. Since bile is the primary route of elimination, this physiological condition requires consideration regarding the appropriate dose of the trace element.

Mechanism of Action

Copper sulphate exerts its mechanism of action primarily through fungicidal activity involving the copper ion (Cu^2+) moiety. The compound acts as an exogenous source of Cu^2+, which is actively transported across the cell membrane of the fungal organism via specific uptake systems. Inside the cell, the Cu^2+ ions accumulate and function as a non-specific inhibitor, interfering with the activity of numerous essential metalloenzymes and structural proteins required for cellular respiration, nutrient metabolism, and structural maintenance. A key target is beta-1,3-glucan synthase, an enzyme involved in maintaining the structural integrity of the fungal cell wall. The inhibition of this and other critical enzymes leads to the formation of pores in the cell wall and membrane, causing an inability to regulate osmotic balance. This loss of cellular compartmentalization results in significant cellular leakage, initiating an irreversible cascade that culminates in fungal cell lysis and death. The Cu^2+ ions generally exhibit lower binding affinity for select enzymes in the host organism.

Dosage and Administration Information

Official Administration and Dosage Principles

Copper Sulphate, used as a source of the essential cupric cation, is exclusively administered via the intravenous (IV) route as an additive to supportive nutritional solutions. The instructions for its use are centered on integration into Total Parenteral Nutrition (TPN) protocols. The medicine must not be administered by direct, undiluted intravenous injection; dilution is mandatory within a large volume of TPN fluid before infusion begins.

Dosing and Frequency

The standard adult dosage, when using a single-element product, typically falls within the range of 0.5 to 1.5 mg of elemental copper per day. This trace element is administered on a once-daily schedule as part of the continuous nutritional infusion. For pediatric patients, the dose is determined based on body weight, generally at 20 mcg per kilogram daily, up to a maximum of 500 mcg per day.

Preparation and Special Conditions

Strict adherence to preparation and handling rules is required. The aseptic addition of the copper supplement to the TPN admixture must be done with caution, and the final solution must be protected from light to maintain stability. A crucial administration rule specifies that the dose may need to be omitted or reduced in patients with known liver or biliary dysfunction, reflecting the body's primary route for processing the mineral. All single-dose vials must have the unused portion discarded immediately after the initial use.

Recent Clinical Evidence

Research evidence / Overview of studies for Copper Sulphate

Evidence for Use in Preventing and Correcting Copper Deficiency

Copper Sulphate injection was studied for its role as an essential trace element source, primarily in patients requiring Total Parenteral Nutrition (TPN). Prospective Balance Studies and Retrospective Reviews examined the body's copper requirements to maintain systemic balance. This foundational research provided context for copper’s inclusion in nutritional formulas, aiming to maintain levels and manage the risk of acquired copper deficiency (Hypocupremia). The high-level evidence for managing deficiency risk is described as robust in scientific literature, though follow-up durations were limited in some foundational balance studies.

Studies Examining Symptoms and Deficiency Reversal

Studies for addressing existing acquired copper deficiency have been studied for the effects on physiological status. This research consists mainly of Case Reports and Case Series that explored the impact of supplementation on outcomes related to systemic imbalance. Research examined lab changes related to deficiency-induced anemia and neutropenia, which were observed in some studies to trend toward normalization. However, the evidence is limited for severe symptoms, and findings are mixed regarding neurological recovery (e.g., peripheral neuropathy), which is often described as partial.

Long-Term Evidence and Durability of Response

Studies typically monitored patients for the duration necessary to confirm the correction of acute deficiency, with time intervals ranging from 4 to 12 weeks. There is limited information regarding the long-term stability of copper status and the durability of deficiency management over many years. Long-term monitoring is typically addressed through observational follow-up, rather than dedicated, extended-duration clinical trials.

Evidence in Special Populations

Copper Sulphate was evaluated in specific populations deemed to be at high risk for deficiency. Research examined outcomes in pediatric populations (e.g., premature infants) and adults with severe malabsorptive conditions (e.g., post-bariatric surgery). The evidence quality varies across studies for these groups, and data for certain groups remain limited for drawing generalized findings across all patients with specific comorbidities.

What is Still Uncertain in the Research Landscape

While the data supporting the role of copper in nutritional support is described as robust, the evidence is limited when assessing the complete restoration of all deficiency symptoms. A major gap is the reliance on case reports and series for the most serious symptoms, meaning that comparative evidence is lacking from large-scale clinical trials for symptomatic care. Also, a single, well-established laboratory measurement of overall body copper status that is reliable in all circumstances is not fully established.

Key Studies & References DailyMed: Prescribing Information for Copper Sulfate Injection

Frequently Asked Questions (FAQ)

Common questions about Copper Sulphate (FAQ)

Q: What are the signs or symptoms of a copper deficiency that would make me need this injection?

Copper Sulphate is intended for use to prevent or correct copper deficiency, particularly in patients receiving specialized nutrition. Official product information describes the symptoms of deficiency that this treatment addresses, which may include Leukopenia (low white blood cells) and Neutropenia, Anemia (low red blood cells), and low levels of key proteins like Ceruloplasmin. Deficiency can also be associated with Osteoporosis (bone weakening).

Q: How long will I need to be on Copper Sulphate treatment?

Official product information notes this trace element is administered as an additive to Total Parenteral Nutrition (TPN) to help maintain copper levels. The duration of therapy depends on the patient’s individual nutritional status. In patients receiving long-term TPN, official labeling notes that monitoring of copper concentrations, such as twice-monthly testing of serum copper or ceruloplasmin, is necessary.

Q: Does Copper Sulphate interact with any foods, drinks, or supplements other than what is listed in the drug interaction chart?

Official labeling highlights specific known incompatibilities within the nutritional solution, such as with Ascorbic Acid (Vitamin C), and mineral balance issues with the trace element Zinc. Beyond these, caution is noted regarding alcohol consumption, as it may exacerbate the risk of liver damage. It is important for patients to discuss all supplements and dietary factors with their healthcare provider.

How should Copper Sulphate be stored and disposed of?

How to Store and Dispose of Copper Sulphate

Storage Requirements

Copper Sulphate solution must be stored in a well-ventilated place and the container must be kept tightly closed to maintain product quality. To preserve stability, the liquid formulation must be stored above 32 °F (0 °C) to prevent freezing . Regulatory information indicates that freezing and subsequent thawing will not affect the product's quality. For safety, the product must be stored locked up and keep out of reach of children.

Disposal Instructions

Disposal of unused product and the container must be conducted in accordance with local/regional/national regulations

. Due to its classification as Very toxic to aquatic life, users must Avoid release to the environment. Contents and containers should be disposed of to an approved waste disposal plant.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Copper Sulphate found in:

A-Z Index: